Aktis Oncology Inc.

AKTS | NASDAQ

Price Alert Chart Builder DCF Calculator

$15.93

-$0.92 (-5.46%)

At close: Oct 30, 2026, 4:00 PM ET

$15.93

$0.00 (0.00%)

After-hours: Oct 30, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024 Dec 31, 2024
Revenue	3.38M	3.23M	1.87M	1.58M	1.6M	1.45M	933K
Cost of Revenue	879K	652K	n/a	n/a	n/a	n/a	n/a
Gross Profit	2.51M	2.58M	1.87M	1.58M	1.6M	1.45M	933K
Operating Income	-28.9M	-22.71M	-17.38M	-18.2M	-20.96M	-18.14M	-15.64M
Interest Income	4.77M	4.38M	2.25M	2.68M	2.91M	3.17M	3.58M
Pretax Income	-24.14M	-18.33M	-15.14M	-15.53M	-18.08M	-14.99M	-12.06M
Net Income	-24.14M	-18.33M	-15.14M	-15.53M	-18.08M	-14.99M	-12.06M
Selling & General & Admin	6.12M	5.25M	2.51M	3.06M	3.68M	3.35M	3.94M
Research & Development	25.28M	20.04M	16.49M	16.47M	18.63M	15.86M	12.61M
Other Expenses	n/a	n/a	242K	254K	255K	381K	21K
Operating Expenses	31.4M	25.28M	19.25M	19.78M	22.56M	19.59M	16.57M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	32.28M	25.93M	19.25M	19.78M	22.56M	19.59M	16.57M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	55.32M	55.28M	53.4M	n/a	52.52M	34.86M	52.52M
Shares Outstanding (Diluted)	55.32M	55.28M	53.4M	n/a	52.52M	34.86M	52.52M
EPS (Basic)	-0.44	-0.33	-0.28	n/a	-0.34	-0.43	-0.23
EPS (Diluted)	-0.44	-0.33	-0.28	n/a	-0.34	-0.43	-0.23
EBITDA	-28.02M	-17.67M	-14.44M	-17.61M	-20.41M	-17.66M	-11.62M
EBIT	-28.9M	-18.33M	-15.14M	-18.2M	-20.96M	-18.14M	-12.06M
Depreciation & Amortization	879K	652K	695K	598K	552K	484K	441K